Business Context and Reporting Period
Company: Cal-Maine Foods, Inc. (CALM)
Filing Type: Form 8-K (Current Report)
Date of Report: April 15, 2025
Reporting Period: Events occurring on April 15, 2025, with transaction completion on April 17, 2025.
Key Financial Metrics and Transaction Details
This filing reports a secondary offering and a concurrent share repurchase rather than standard operating financial results.
- Secondary Offering: 2,978,740 shares of Common Stock sold by Selling Stockholders (founder's family) at $92.75 per share.
- Company Proceeds: $0 (The Company did not offer or sell shares and received no proceeds).
- Share Repurchase: The Company repurchased 551,876 shares from the Selling Stockholders.
- Repurchase Cost: Approximately $50 million.
- Remaining Repurchase Authorization: Approximately $450 million remaining under the $500 million program approved on February 25, 2025.
Material Changes Versus Prior Period
The filing does not provide comparative financial data (revenue, profit, cash flow) against prior periods. The material change reported is the reduction of the Company's share repurchase program balance by approximately $50 million and the change in ownership structure due to the sale of shares by the Selling Stockholders.
Guidance, Outlook, and Management Commentary
Management Action: A special committee of independent and disinterested directors approved both the Offering and the Share Repurchase.
Legal Counsel: Sidley Austin LLP issued an opinion regarding the Offering.
Outlook: The filing contains no forward-looking guidance regarding revenue, earnings, or market conditions. The transaction was executed pursuant to an automatic shelf registration statement on Form S-3.
Important Facts for Investor Verification
- Verify that the Company received no proceeds from the secondary offering, as the shares were sold by the Selling Stockholders.
- Confirm the remaining balance of the share repurchase program is approximately $450 million.
- Note that the repurchase price matched the underwriter's purchase price in the secondary offering.
- Review the attached Underwriting Agreement (Exhibit 1.1) and Stock Repurchase Agreement (Exhibit 99.1) for specific indemnification and termination provisions.